IRIS
CUSI, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.356
EU - Europa 15.604
AS - Asia 8.423
SA - Sud America 1.599
AF - Africa 573
Continente sconosciuto - Info sul continente non disponibili 522
OC - Oceania 34
Totale 46.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.029
IT - Italia 3.090
RU - Federazione Russa 3.003
GB - Regno Unito 2.746
CN - Cina 2.714
SG - Singapore 2.545
IE - Irlanda 2.008
BR - Brasile 1.284
UA - Ucraina 978
SE - Svezia 957
VN - Vietnam 908
FR - Francia 864
DE - Germania 854
HK - Hong Kong 721
FI - Finlandia 498
KR - Corea 411
ZA - Sudafrica 299
IN - India 275
BD - Bangladesh 177
CA - Canada 170
TR - Turchia 115
ES - Italia 112
NL - Olanda 101
IQ - Iraq 92
PL - Polonia 89
AR - Argentina 85
NG - Nigeria 73
CI - Costa d'Avorio 65
MX - Messico 64
PK - Pakistan 62
EC - Ecuador 61
BE - Belgio 55
JP - Giappone 55
CO - Colombia 53
ID - Indonesia 53
AT - Austria 50
SA - Arabia Saudita 44
VE - Venezuela 43
CZ - Repubblica Ceca 42
KE - Kenya 28
UZ - Uzbekistan 26
CL - Cile 25
MA - Marocco 25
PH - Filippine 25
AU - Australia 23
MY - Malesia 21
EU - Europa 19
PE - Perù 19
JM - Giamaica 18
NP - Nepal 17
AE - Emirati Arabi Uniti 16
AL - Albania 16
JO - Giordania 16
LT - Lituania 16
EG - Egitto 15
TN - Tunisia 14
DZ - Algeria 13
KZ - Kazakistan 13
PA - Panama 13
PT - Portogallo 13
CR - Costa Rica 12
IL - Israele 12
PY - Paraguay 12
RS - Serbia 12
HN - Honduras 11
TH - Thailandia 11
UY - Uruguay 11
GR - Grecia 10
IM - Isola di Man 10
NZ - Nuova Zelanda 10
SC - Seychelles 10
CH - Svizzera 9
ET - Etiopia 9
IR - Iran 9
AZ - Azerbaigian 8
TT - Trinidad e Tobago 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
HU - Ungheria 7
LB - Libano 7
PS - Palestinian Territory 7
AM - Armenia 6
EE - Estonia 6
GE - Georgia 6
GH - Ghana 6
MT - Malta 6
NO - Norvegia 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
CY - Cipro 5
DK - Danimarca 5
HR - Croazia 5
KW - Kuwait 5
NI - Nicaragua 5
OM - Oman 5
QA - Qatar 5
RO - Romania 5
BB - Barbados 4
GT - Guatemala 4
KG - Kirghizistan 4
Totale 45.534
Salva come PNG Salva come JPEG
Città #
Southend 2.288
Dallas 2.009
Dublin 1.969
Ashburn 1.604
Fairfield 1.485
Singapore 1.471
Chandler 1.124
San Jose 959
Moscow 856
Santa Clara 839
Jacksonville 781
Woodbridge 770
Milan 724
Hong Kong 665
Beijing 664
Seattle 639
Wilmington 624
Houston 590
Cambridge 535
Hefei 508
Siena 507
Ann Arbor 498
Council Bluffs 491
Seoul 397
Princeton 338
Los Angeles 317
Rome 279
New York 276
Ho Chi Minh City 268
Nanjing 268
Johannesburg 267
Helsinki 242
Menlo Park 233
The Dalles 232
Lauterbourg 223
Hanoi 214
Munich 193
Boardman 150
Buffalo 126
São Paulo 123
Florence 117
San Mateo 115
Nanchang 97
San Diego 93
London 81
Orem 78
Fremont 75
Shanghai 72
Abuja 70
Frankfurt am Main 68
Redondo Beach 68
Dong Ket 67
Abidjan 65
Chicago 64
Columbus 62
Turku 62
Warsaw 61
Atlanta 58
Dearborn 57
Bengaluru 56
Málaga 56
Montreal 54
Shenyang 54
Hebei 52
Brussels 50
Tianjin 49
Toronto 49
Izmir 47
Chennai 46
Tokyo 46
Da Nang 45
Rio de Janeiro 45
Lappeenranta 41
San Francisco 41
Figino 39
Phoenix 39
Changsha 38
Guangzhou 38
Norwalk 38
Lancaster 37
Haiphong 36
Nuremberg 34
Turin 34
Washington 34
Brooklyn 33
Düsseldorf 32
Jiaxing 32
Vienna 32
Kunming 31
Baghdad 29
Brasília 29
Stockholm 29
Venezia 29
Porto Alegre 27
Tashkent 26
Bologna 25
Dhaka 25
Amsterdam 24
Belo Horizonte 24
Boston 24
Totale 29.725
Salva come PNG Salva come JPEG
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 416
Immune response analysis to Measles virus in subjects vaccinated with MMR vaccine and naturally infected subjects. 404
Diagnostic tools for Toscana virus infection 403
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 395
Valutazione di un test in chemiluminescenza per la diagnosi sierologica di Leishmaniosi Viscerale 387
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 382
Andamento longitudinale di biomarkers di infiammazione ed immunoattivazione in pazienti sottoposti a trapianto di rene: un ruolo della replicazione di CMV? 372
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. 363
ERITEMA NODOSO RECIDIVANTE E PERSISTENTE REPLICA DI EPSTEIN-BARR VIRUS 358
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 345
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection. 342
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 336
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 335
Peripheral biomarkers' panel for severe COVID-19 patients 328
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. 320
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 318
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 309
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge 308
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 301
HCMV infection in renal transplant recipients: a retrospective cohort study 299
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia 296
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 295
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 287
Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection 284
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 281
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 279
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 279
Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy [Sieroprevalenza dell’infezione da virus dell’epatite E (HEV) in donatori di sangue e pazienti trapiantati di rene: Uno studio retrospettivo dal centro Italia] 275
Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro 275
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 273
Beyond the biological effect of a chemically characterized poplar propolis: Antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by LPS-stimulated human mononuclear cells 272
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 271
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. 268
Dendritic cell-cediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro 267
Peptidi epitopici immunogenici del CEA da utilizzare nella chemio-immunoterapia del carcinoma del colon-retto e della mammella. 266
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 266
In vitro neuraminidase inhibitory effect and activity against influenza virus A H1N1 of herbal drugs used for common cold 262
Serial KL-6 measurements in COVID-19 patients 257
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. 256
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 255
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 253
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 249
Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy 249
Testicular involvement during Toscana-virus infection: an unusual manifestation? 248
FIBRILLO-FLUTTER IN ASSENZA DI SEGNI DI MIOCARDITE IN CORSO DI INFEZIONE DA EBV 247
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers 246
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 241
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects 239
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes 238
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 236
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 235
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus 235
A Poly-epitopic peptide vaccine against the thymidylate synthase (TS). A synergistic therapeutic combination with fluoropyrimidine-based-chemotherapy 232
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 232
Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine 231
SARS-CoV-2 in pleural fluid in a kidney transplant patient 227
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 226
Chemo-immunotherapy of colo-rectal cancer: Drug induced antigen specific cell-mediated immune response in vitro and in cancer patients 226
Identification of a neutralizing epitope on tosv gn glycoprotein 225
Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis 225
A Polyepitope DNA Vaccine Targeted to Her-2/ErbB-2 Elicits a Broad Range of Human and Murine CTL Effectors to Protect against Tumor Challenge 223
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 223
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 222
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 221
Pathogenic mechanism of Helicobacter pylori: production of cytoxin 221
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. 219
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 219
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 219
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy 218
Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity 217
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients 217
Effetti della dieta sulla secrezione di calcitonina nel neonato [The effects of diet on the secretion of calcitonin in the newborn infant] 216
Detection of RSV Genome in Cerebrospinal Fluid of a Patient with Guillain Barrè Syndrome: A Case Report 214
Compartimentalizzazione di HCMV: mancata appropiatezza della sola DNAemia nella diagnosi e nella terapia di una polmonite da HCMV post-trapianto polmonare 214
A Mediterranean arbovirus: the Toscana virus 211
Virosoma dell'influenza immunoricostituito (IRIV) contenente il gene per CD40L come immunoprotettore tumorale CEA-specifico e usi immunogenici di esso. 211
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 210
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector 209
Seroprevalence of antibodies to Sandfly fever Sicilian virus in a sample population in Tuscany, Italy 208
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine 207
Infection prevention in endoscopy practice; comparative evaluation of reusable vs single use endoscopic valves 207
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 206
Synthetic peptides of rubella E1 glycoprotein for serological assays 206
Applications of Influenza Virosomes as a delivery system 204
Age-dependent seroprevalence of Toscana virus in central Italy and correlation with the clinical profile 204
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 202
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 198
Epidemiological and clinical study of viral respiratory tract infections in children from Italy 198
Development of a mouse model for the study of Toscana virus pathogenesis 198
ACKNOWLEDGEMENT OF REVIEWERS 197
Immunological characterization of Respiratory Syncytial Virus N protein epitopes recognized by human cytotoxic T lymphocytes 196
Toscana Virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. 196
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 194
Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route 194
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 194
Infections in liver and lung transplant recipients: A national prospective cohort 191
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 190
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 190
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 190
Nucleotide variability of Toscana virus M segment in strains isolated from clinical cases 187
Totale 25.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 144.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.118
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.007 0 0 0 200 127 88 121 141 218 279 249 584
2022/20234.058 248 324 509 539 412 817 80 349 424 102 166 88
2023/20243.124 109 108 267 178 101 817 1.073 76 18 77 64 236
2024/20256.357 181 354 556 342 713 354 306 376 554 280 647 1.694
2025/202615.136 1.156 2.111 1.574 1.787 2.714 621 1.651 541 582 811 421 1.167
2026/20272.571 597 658 1.305 11 0 0 0 0 0 0 0 0
Totale 46.111